CLINICAL STUDIES
The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans
Stephan Windecker, MDa,
Raymond E. Ideker, MD, PhD, FACCa,
Vance J. Plumb, MD, FACCa,
G. Neal Kay, MD, FACCa,
Gregory P. Walcott, MDa and
Andrew E. Epstein, MD, FACCa
a Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA
Manuscript received May 28, 1998;
revised manuscript received August 13, 1998,
accepted September 15, 1998.
Address for correspondence: Andrew E. Epstein, MD, Division of Cardiovascular Disease, The University of Alabama at Birmingham, University Station THT 321, Birmingham, Alabama 35294 aepstein{at}uab.edu
Objectives. The purpose of this study was to prospectively investigate the influence of ventricular fibrillation (VF) durations of 5, 10 and 20 s on the defibrillation threshold (DFT) during implantable cardioverterdefibrillator (ICD) implantation.
Background. Although the DFT using monophasic waveforms has been shown to increase with VF duration in humans, the effect of VF duration on defibrillation efficacy using biphasic waveforms in humans is not known.
Methods. Thirty patients undergoing primary ICD implantation or pulse generator replacement were randomly assigned to have the DFT determined using biphasic shocks at two durations of VF each (5 and 10 s, 10 and 20 s or 5 and 20 s).
Results. There was no statistically significant difference in the mean DFT comparing VF durations of 5 s (9.5 ± 6.0 J) and 10 s (10.8 ± 7.0 J) (p = 0.4). The mean DFT significantly increased from 10.9 ± 6.1 J at 10 s of VF to 12.6 ± 5.6 J (p = 0.03) at 20 s of VF, and from 7.0 ± 3.5 J at 5 s of VF to 10.5 ± 6.3 J (p = 0.04) at 20 s of VF. An increase in the DFT was observed in 14 patients as VF duration increased. There were no clinical characteristics that differentiated patients with and without an increase in the DFT.
Conclusions. Defibrillation efficacy decreases with increasing VF duration using biphasic waveforms in humans. Ventricular fibrillation durations greater than 10 s may negatively affect the effectiveness of ICD therapy.
|
Abbreviations and Acronyms
| | DFT | = defibrillation threshold | | ICD | = implantable cardioverterdefibrillator | | VF | = ventricular fibrillation |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Kudenchuk, L. A. Cobb, M. K. Copass, M. Olsufka, C. Maynard, and G. Nichol
Transthoracic Incremental Monophasic Versus Biphasic Defibrillation by Emergency Responders (TIMBER): A Randomized Comparison of Monophasic With Biphasic Waveform Ascending Energy Defibrillation for the Resuscitation of Out-of-Hospital Cardiac Arrest due to Ventricular Fibrillation
Circulation,
November 7, 2006;
114(19):
2010 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Wathen, M. O. Sweeney, P. J. DeGroot, A. J. Stark, J. L. Koehler, M. B. Chisner, C. Machado, and W. O. Adkisson
Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease
Circulation,
August 14, 2001;
104(7):
796 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schulte, J. Sperzel, J. Carlsson, T. Schwarz, W. Ehrlich, H. F. Pitschner, and J. Neuzner
Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements
Europace,
January 1, 2001;
3(3):
177 - 180.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Ideker, A. E. Epstein, and G. P. Walcott
Is there an optimal capacitance for defibrillation?
Europace,
January 1, 2001;
3(4):
275 - 277.
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Leng, N. A. Paradis, H. Calkins, R. D. Berger, A. C. Lardo, K. C. Rent, and H. R. Halperin
Resuscitation After Prolonged Ventricular Fibrillation With Use of Monophasic and Biphasic Waveform Pulses for External Defibrillation
Circulation,
June 27, 2000;
101(25):
2968 - 2974.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|